Perspective Therapeutics Inc. Dividends
The next dividend date for Perspective Therapeutics Inc. has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Perspective Therapeutics Inc. (CATX)
More About Perspective Therapeutics Inc.
Perspective Therapeutics, Inc., together with its subsidiaries, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. The company discovers, and develop its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a beta emitting therapy; VMT01, which is in Phase 1/2a clinical trials for second-line or later treatment of patients with progressive melanocortin 1 receptor (MC1R) positive metastatic melanoma; PSV359, a targeted alpha therapy targeting fibroblast activation protein alpha; and PSV4XX, a differentiated prostate-specific membrane antigen-targeted alpha therapy. It has a clinical trial collaboration agreement with Bristol Myers Squibb to evaluate the safety and tolerability of [212Pb] VMT01 in combination with nivolumab in patients with histologically confirmed melanoma and positive MC1R imaging scans. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 2004 and is headquartered in Seattle, Washington.
Owning Perspective Therapeutics Inc. Stock on the Dividend Date
If you own Perspective Therapeutics Inc. stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Perspective Therapeutics Inc. stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Perspective Therapeutics Inc. stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Perspective Therapeutics Inc. stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Perspective Therapeutics Inc. dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Perspective Therapeutics Inc. Dividends
You can contact us any time if you would like to ask questions about Perspective Therapeutics Inc. dividends or anything else related to the stock market.